- About Us
- Career Center
- Nano-Social Network
- Nano Consulting
- My Account
National survey finds support for research but with oversight and greater attention to risks
Synthetic biology—defined as the design and construction of new biological parts, devices, and systems or re-design of existing natural biological systems for useful purposes—holds enormous potential to improve everything from energy production to medicine, with the global market projected to reach $4.5 billion by 2015. But what does the public know about this emerging field, and what are their hopes and concerns? A new poll of 1,000 U.S. adults conducted by Hart Research Associates and the Synthetic Biology Project at the Woodrow Wilson Center finds that two-thirds of Americans think that synthetic biology should move forward, but with more research to study its possible effects on humans and the environment, while one-third support a ban until we better understand its implications and risks. More than half of Americans believe the federal government should be involved in regulating synthetic biology.
"The survey clearly shows that much more attention needs to be paid to addressing biosafety and biosecurity risks," said David Rejeski, Director of the Synthetic Biology Project. "In addition, government and industry need to engage the public about the science and its applications, benefits, and risks." The poll findings reveal that the proportion of adults who say they have heard a lot or some about synthetic biology has almost tripled in three years, (from 9 percent to 26 percent). By comparison, self-reported awareness of nanotechnology increased from 24 percent to 34 percent during the same three-year period.
Although the public supports continued research in the area of synthetic biology, it also harbors concerns, including 27 percent who have security concerns (concerns that the science will be used to make harmful things), 25 percent who have moral concerns, and a similar proportion who worry about negative health consequences for humans. A smaller portion, 13 percent, worries about possible damage to the environment.
"The survey shows that attitudes about synthetic biology are not clear-cut and that its application is an important factor in shaping public attitudes towards it," said Geoff Garin, President of Hart Research. Six in 10 respondents support the use of synthetic biology to produce a flu vaccine. In contrast, three-fourths of those surveyed have concerns about its use to accelerate the growth of livestock to increase food production. Among those for whom moral issues are the top concern, the majority views both applications in a negative light. The findings come from a nationwide telephone survey of 1,000 adults and has a margin of error of ± 3.1 percentage points. This is the fifth year that Hart Research Associates has conducted a survey to gauge public opinion about nanotechnology and/or synthetic biology for the Woodrow Wilson International Center for Scholars.
Download the report here www.synbioproject.org/process/assets/files/6451/_draft/hart_revised_.pdf
About Synthetic Biology Project at the Woodrow Wilson Center
The Synthetic Biology Project was established as an initiative of the Foresight & Governance Program of the Woodrow Wilson International Center for Scholars.
The Project aims to foster informed public and policy discourse concerning the advancement of synthetic biology – an emerging interdisciplinary field that uses advanced science and engineering to make or re-design living organisms, such as bacteria, so they can carry out specific functions. Synthetic biology involves making new genetic code, also known as DNA, which does not already exist in nature.
The Synthetic Biology Project provides independent, rigorous analysis that can inform critical decisions affecting the research, commercialization and use of synthetic biology. Its objective is to help ensure that, as synthetic biology moves forward, possible risks are minimized and benefits maximized.
In collaboration with researchers, governments, industries, non-governmental organizations, policymakers and others, the Project will work to identify gaps in our knowledge of the potential risks of synthetic biology, explore public perceptions towards the field, and examine governance options that will both ensure public safety and facilitate innovation.
All research results, reports, and the outcomes of our meetings and programs will be made broadly available through publications and over the World Wide Web. We include a wide variety of stakeholders, both domestic and international, in our work.
For more information, please click here
Woodrow Wilson International Center for Scholars
One Woodrow Wilson Plaza
1300 Pennsylvania Ave., NW,
Washington, DC 20004-3027
Phone: (202) 691-4398
Fax: (202) 691-4001
Copyright © Synthetic Biology Project at the Woodrow Wilson CenterIf you have a comment, please Contact us.
Issuers of news releases, not 7th Wave, Inc. or Nanotechnology Now, are solely responsible for the accuracy of the content.
|Related News Press|
News and information
The magic of microbes: ONR engineers innovative research in synthetic biology February 19th, 2016
Chemical cages: New technique advances synthetic biology February 10th, 2016
DNA 'building blocks' pave the way for improved drug delivery January 12th, 2016
Imitating synapses of the human brain could lead to smarter electronics November 15th, 2015
Preparing for Nano
Searching for a nanotech self-organizing principle May 1st, 2016
Nanotechnology is changing everything from medicine to self-healing buildings: Nanotechnology is so small it's measured in billionths of metres, and it is revolutionising every aspect of our lives April 2nd, 2016
Durnham University's DEEPEN project comes to a close September 26th, 2012
Technical Seminar at ANFoS 2012 August 22nd, 2012
Interviews/Book Reviews/Essays/Reports/Podcasts/Journals/White papers
The impact of anti-odor clothing on the environment March 31st, 2016
SUNY Poly, in Collaboration with the George Washington School of Medicine and Health Sciences and Stony Brook University, Demonstrates Pioneering Method to Visualize and Identify Engineered Nanoparticles in Tissue March 25th, 2016